Tysabri (tie-SAB-ree), the latest investigational treatment for multiple sclerosis (MS)

January 2005

There's a lot of excitement about Tysabri (tie-SAB-ree), the latest investigational treatment for multiple sclerosis (MS).

Tysabri (natalizumab) is a monoclonal antibody. It blocks immune cells from entering the CNS and attacking nerves.

It seems to be more effective than the other MS drugs.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

concerns over potentially harmful drugs
Antiarrhythmics flecainide (Tambocor) or propafenone (Rythmol) written "take as needed for atrial fibrillation"
Cardiology Reps will be saying that amlodipine (Norvasc) reduces the risk of cardiovascular events
Humira, a new biologic therapy for rheumatoid arthritis
Light therapy is often as effective as antidepressants for seasonal affective disorder (SAD)
Ritalin, Adderall, and other stimulants to enhance test scores
Diabetes Reps will be touting evidence that suggests carvedilol is better than metoprolol for diabetes patients
Multiple Sclerosis Tysabri (tie-SAB-ree), the latest investigational treatment for multiple sclerosis (MS)
Multiple Sclerosis Aricept and other cholinesterase inhibitors for patients with multiple sclerosis
Supplements Cold-fX is getting a LOT of attention for treating and preventing colds
Supplements Is it legal to have melatonin on the shelves in Canada
Women's Health the risk of bone loss in women using Depo-Provera
Women's Health whether testosterone is appropriate for treating sexual dysfunction in women
Hematology & Oncology More women with EARLY breast cancer will be treated with an aromatase inhibitor
Infectious Diseases treatment for gonorrhea has changed
Infectious Diseases malaria prophylaxis for travellers to the Dominican Republic
Practice End of year is a good time to reflect on trustworthy drug information that is relevant to practice.